Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.21.2
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Aug. 29, 2019
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2019
Mar. 19, 2022
Dec. 31, 2020
Mar. 18, 2019
Related Party Transactions (Details) [Line Items]                  
Genexosome for Cash payment       $ 450,000          
Accrued liabilities and other payables   $ 259,236   259,236       $ 167,956  
Outstanding principal balance   390,000   390,000       390,000  
Promissory note maturity date Dec. 31, 2024                
Outstanding line of credit   3,393,188   3,393,188       $ 3,200,000  
Interest expense related party   46,131 $ 42,469 91,280 $ 84,638        
Dr. Yu Zhou [Member]                  
Related Party Transactions (Details) [Line Items]                  
Consideration cash   $ 100,000   $ 100,000          
Genexosome [Member]                  
Related Party Transactions (Details) [Line Items]                  
Ownership of percentage   40.00%   40.00%       40.00%  
Wenzhao Lu [Member]                  
Related Party Transactions (Details) [Line Items]                  
Consideration cash                 $ 1,000,000
Outstanding principal balance                 $ 1,000,000
Promissory Note interest percentage             5.00%    
Principal repaid amount         $ 200,000 $ 410,000      
Line of Credit Agreement [Member]                  
Related Party Transactions (Details) [Line Items]                  
Line of credit $ 20,000,000                
Interest rate 5.00%                
Board of Directors [Member] | Wenzhao Lu [Member]                  
Related Party Transactions (Details) [Line Items]                  
Accrued liabilities and other payables   $ 259,236   $ 259,236       $ 167,956